Christopher Khorsandi, MD is the Chief Medical Officer of Tiger Aesthetics and a board-certified plastic surgeon based in Henderson, Nevada. He is a physician-executive with deep experience across aesthetic surgery, regenerative medicine, soft-tissue reconstruction, clinical product development, and physician education. In addition to his clinical practice at VIP Plastic Surgery, Dr. Khorsandi serves as a scientific and strategic leader for Tiger Aesthetics, helping guide clinical strategy, product innovation, medical affairs, and physician-facing education across the company’s aesthetic medicine portfolio.

Dr. Khorsandi has contributed to translational research in human adipose allograft technology, including work in developing and evaluating alloClae, a ready-to-use human adipose allograft designed for homologous soft-tissue repair and replacement applications. His published and submitted scientific work has focused on biocompatibility, extracellular matrix preservation, host tissue integration, adipogenesis, angiogenesis, and the evolving role of human-derived tissue technologies in reconstructive soft-tissue applications.

As CMO, Dr. Khorsandi is focused on advancing evidence-based, compliant innovation in aesthetic biotechnology while supporting physicians with practical clinical education, responsible adoption, and patient-centered outcomes.